First-line vs Second-Line Catheter Ablation Therapy for Patients with Atrial Fibrillation—Data from a National Multicentre Registry

IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

CJC Open Pub Date : 2025-04-01 DOI:10.1016/j.cjco.2025.01.014

Ranin Hilu MD , Mahmoud Suleiman MD , Adi Elias MD, MPH , Ibrahim Marai MD , Roy Beinart MD , Eyal Nof MD , Yoav Michowitz MD , Michael Glikson MD , Yuval Konstantino MD , Moti Haim MD , David Luria MD , David Pereg MD , Avishag Laish-Farkash MD, PhD , Alexander Omelchenko MD , Israeli Working Group on Pacing and Electrophysiology

{"title":"First-line vs Second-Line Catheter Ablation Therapy for Patients with Atrial Fibrillation—Data from a National Multicentre Registry","authors":"Ranin Hilu MD , Mahmoud Suleiman MD , Adi Elias MD, MPH , Ibrahim Marai MD , Roy Beinart MD , Eyal Nof MD , Yoav Michowitz MD , Michael Glikson MD , Yuval Konstantino MD , Moti Haim MD , David Luria MD , David Pereg MD , Avishag Laish-Farkash MD, PhD , Alexander Omelchenko MD , Israeli Working Group on Pacing and Electrophysiology","doi":"10.1016/j.cjco.2025.01.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>An early catheter ablation treatment strategy is effective for rhythm control in patients with atrial fibrillation (AF). In clinical practice, most patients undergo catheter ablation as a second-line treatment, following a trial of antiarrhythmic drugs (AADs). We aimed to investigate the effectiveness and safety of AF catheter ablation performed as a first-line vs a second-line approach, based on data from the nationwide, multicentre Israeli Catheter Ablation Registry.</div></div><div><h3>Methods</h3><div>Following AF catheter ablation, patients were stratified into 2 groups—first-line vs second-line therapy approaches. The second-line group included AF patients who were referred for catheter ablation following treatment with at least one AAD. The primary endpoint was the 1-year freedom from AF recurrence. The secondary endpoints included 1-year hospitalizations, death, cerebrovascular events, and the composite of adverse cardiac events.</div></div><div><h3>Results</h3><div>The 923 participants had a mean age of 66 ± 4.5 years. Catheter ablation was performed as a first-line therapy in 192 patients (20.8%). Median times from AF diagnosis to catheter ablation were 1.5 and 3 years in the first- and second-line groups, respectively. Patients in the first-line group were younger, had a shorter AF duration, and more frequently had a normal left atrial size prior to the procedure. The primary endpoint of AF recurrence at 1 year did not differ significantly between the groups (24.9% vs 30%, <em>P</em> = 0.205). No significant differences in the incidence of secondary outcomes occurred.</div></div><div><h3>Conclusions</h3><div>Mildly delayed AF catheter ablation for patients with AF did not compromise the procedure’s efficacy or safety.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 4","pages":"Pages 429-434"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CJC Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589790X25000423","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

An early catheter ablation treatment strategy is effective for rhythm control in patients with atrial fibrillation (AF). In clinical practice, most patients undergo catheter ablation as a second-line treatment, following a trial of antiarrhythmic drugs (AADs). We aimed to investigate the effectiveness and safety of AF catheter ablation performed as a first-line vs a second-line approach, based on data from the nationwide, multicentre Israeli Catheter Ablation Registry.

Methods

Following AF catheter ablation, patients were stratified into 2 groups—first-line vs second-line therapy approaches. The second-line group included AF patients who were referred for catheter ablation following treatment with at least one AAD. The primary endpoint was the 1-year freedom from AF recurrence. The secondary endpoints included 1-year hospitalizations, death, cerebrovascular events, and the composite of adverse cardiac events.

Results

The 923 participants had a mean age of 66 ± 4.5 years. Catheter ablation was performed as a first-line therapy in 192 patients (20.8%). Median times from AF diagnosis to catheter ablation were 1.5 and 3 years in the first- and second-line groups, respectively. Patients in the first-line group were younger, had a shorter AF duration, and more frequently had a normal left atrial size prior to the procedure. The primary endpoint of AF recurrence at 1 year did not differ significantly between the groups (24.9% vs 30%, P = 0.205). No significant differences in the incidence of secondary outcomes occurred.